Yang H, Zhao Y, Ren B, Wu Y, Qiu Z, Cheng Y
Heliyon. 2024; 10(10):e31106.
PMID: 38779018
PMC: 11109894.
DOI: 10.1016/j.heliyon.2024.e31106.
Islam M, Jang N, Lee H
Biomedicines. 2024; 12(4).
PMID: 38672151
PMC: 11048580.
DOI: 10.3390/biomedicines12040794.
Chang X, Tan Q, Xu J, Wu X, Wang Y, Zhang Y
Cancer Cell Int. 2023; 23(1):287.
PMID: 37990331
PMC: 10664679.
DOI: 10.1186/s12935-023-03121-3.
Gupta S, Raisanen I, Seppanen H, Hagstrom J, Grigoriadis A, Hermunen K
Cancer Control. 2023; 30:10732748231214874.
PMID: 37964755
PMC: 10647922.
DOI: 10.1177/10732748231214874.
Eiro N, Medina A, Gonzalez L, Fraile M, Palacios A, Escaf S
Int J Mol Sci. 2023; 24(8).
PMID: 37108185
PMC: 10139111.
DOI: 10.3390/ijms24087022.
Screening and identification of miR-181a-5p in oral squamous cell carcinoma and functional verification in vivo and in vitro.
Xu G, Yang Y, Yang J, Xiao L, Wang X, Qin L
BMC Cancer. 2023; 23(1):162.
PMID: 36800936
PMC: 9936757.
DOI: 10.1186/s12885-023-10600-3.
Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review.
Mustafa S, Koran S, Alomair L
Front Mol Biosci. 2022; 9:896099.
PMID: 36250005
PMC: 9557123.
DOI: 10.3389/fmolb.2022.896099.
Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors.
Tune B, Sim M, Poh C, Guad R, Woon C, Hazarika I
J Oncol. 2022; 2022:3249766.
PMID: 35586209
PMC: 9110224.
DOI: 10.1155/2022/3249766.
Anti-POSTN and Anti-TIMP1 Autoantibodies as Diagnostic Markers in Esophageal Squamous Cell Carcinoma.
Xie W, Sun G, Zhu J, Wang H, Han Z, Wang P
Front Genet. 2022; 13:860611.
PMID: 35559040
PMC: 9087588.
DOI: 10.3389/fgene.2022.860611.
Metastasis and MAPK Pathways.
Kciuk M, Gielecinska A, Budzinska A, Mojzych M, Kontek R
Int J Mol Sci. 2022; 23(7).
PMID: 35409206
PMC: 8998814.
DOI: 10.3390/ijms23073847.
TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients.
He W, Liu C, Liao J, Liu F, Lei H, Wei D
Front Med (Lausanne). 2022; 8:774623.
PMID: 35284430
PMC: 8914225.
DOI: 10.3389/fmed.2021.774623.
Shared brain transcriptomic signature in TDP-43 type A FTLD patients with or without GRN mutations.
Pottier C, Mateiu L, Baker M, DeJesus-Hernandez M, Teixeira Vicente C, Finch N
Brain. 2021; 145(7):2472-2485.
PMID: 34918030
PMC: 9337811.
DOI: 10.1093/brain/awab437.
Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Echinoderms: Structure and Possible Functions.
Dolmatov I, Nizhnichenko V, Dolmatova L
Cells. 2021; 10(9).
PMID: 34571980
PMC: 8467561.
DOI: 10.3390/cells10092331.
Expression of , , , and during Gut Regeneration in Holothurian (Holothuroidea, Dendrochirotida).
Dolmatov I, Kalacheva N, Tkacheva E, Shulga A, Zavalnaya E, Shamshurina E
Genes (Basel). 2021; 12(8).
PMID: 34440466
PMC: 8391186.
DOI: 10.3390/genes12081292.
Xanthohumol Impairs the PMA-Driven Invasive Behaviour of Lung Cancer Cell Line A549 and Exerts Anti-EMT Action.
Slawinska-Brych A, Mizerska-Kowalska M, Krol S, Stepulak A, Zdzisinska B
Cells. 2021; 10(6).
PMID: 34204745
PMC: 8231538.
DOI: 10.3390/cells10061484.
Mediators of extracellular matrix degradation and inflammation: A new team of possible biomarkers for oral squamous cell carcinoma stage.
Radulescu R, Ripszky Totan A, Melescanu Imre M, Miricescu D, Didilescu A, Greabu M
Exp Ther Med. 2021; 22(2):877.
PMID: 34194555
PMC: 8237384.
DOI: 10.3892/etm.2021.10309.
The prognostic and diagnostic value of tissue inhibitor of metalloproteinases gene family and potential function in gastric cancer.
Li Z, Jing Q, Wu L, Chen J, Huang M, Qin Y
J Cancer. 2021; 12(13):4086-4098.
PMID: 34093812
PMC: 8176236.
DOI: 10.7150/jca.57808.
Relationship between Metalloprotease-7 and -14 and Tissue Inhibitor of Metalloprotease 1 Expression by Mucosal Stromal Cells and Colorectal Cancer Development in Inflammatory Bowel Disease.
Altadill A, Eiro N, Gonzalez L, Andicoechea A, Fernandez-Francos S, Rodrigo L
Biomedicines. 2021; 9(5).
PMID: 33946534
PMC: 8147221.
DOI: 10.3390/biomedicines9050495.
Joint Tumor Bud-MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma.
Gonzalez L, Eiro N, Fraile M, Sanchez R, Andicoechea A, Fernandez-Francos S
Biomedicines. 2021; 9(2).
PMID: 33669393
PMC: 7920253.
DOI: 10.3390/biomedicines9020196.
Carotenoids in Cancer Metastasis-Status Quo and Outlook.
Koklesova L, Liskova A, Samec M, Zhai K, Abotaleb M, Ashrafizadeh M
Biomolecules. 2020; 10(12).
PMID: 33321708
PMC: 7763577.
DOI: 10.3390/biom10121653.